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INTRODUCTION
Globally, 4% of all cancer-related deaths are attributed to
mouth, pharynx and larynx, and they are the 8th most com-
mon cause of death from cancer. In the Baltic countries,
oral cavity cancer composes 1.1 to 2% of all malignancies
and 5-year prevalence varied from 19.74% in Estonia to
37.98% in Latvia (Anonymous, 2018). In the Northern Eu-
rope countries, including Latvia, in recent years young peo-
ple have increased usage of smokeless tobacco, which along
with alcohol consumption, smoking, and chronic inflamma-
tory processes of oral mucosa are possible causes of poten-
tially premalignant disorders and oral malignancies. The
most common precursors of oral squamous cell cancer are
oral leukoplakia, erythroplakia, submucosal fibrosis and
erosive and atrophic forms of oral lichen ruber planus
(Renaud-Vilmer and Cavelier-Balloy, 2017; Sundberg et
al., 2019).
The role of oral leukoplakia (OL) in the development of
oral cancer has been discussed in literature for many de-
cades (Roye et al., 1996; Wang et al., 2009; Garcia et al.,
2019). There have been attempts to identify other risk fac-
tors for malignant transformation of OL into cancer: leuko-
plakias mainly of tongue or of the floor of mouth, its size
larger than 2 cm, and the non-homogeneous type (Assi-
makopoulos et al., 2002; Speight et al., 2018). However,
most scientists and dentists agree that the key factor for ma-
lignant transformation processes of squamous epithelium in
different organs is severe dysplasia (Herold-Mende, 1996;
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It is essential to identify markers that could indicate the presence of early molecular changes in
premalignant tissues like oral leukoplakia (OL). CD44 adhesion molecule is not only a stem cell
marker, but also determines cell proliferation and migration in malignant processes. The aim of
our study was to assess the amount and pattern of CD44 antigen expression by epithelial and
mononuclear cells in the lamina propria under OL and their role in premalignant lesions. The cur-
rent study included 102 cases of OL and ten biopsies from healthy oral mucosa. Immuno-
histochemical CD44 antigen expression was determined in 34 cases by a standard EnVision
imaging system in three points of OL: both edges and centre. Statistical analysis was done using
GraphPad Prism software version 8.4.0. In OL, statistically significant overexpression of membra-
nous CD44 was demonstrated compared to healthy mucosa (p < 0.0001). The intra-cytoplasmatic
CD44 expression of epithelium together with characteristic nuclear changes may be used as a
predictive factor for potential malignant transformation of non-homogenous leukoplakia. CD44 ex-
pression in mononuclear cells under the basal membrane in OL (p < 0.05) possibly influences the
process of premalignant lesion transformation into intraepithelial cancer. Further study of CD44
antigen expression in intra-cytoplasmatic structures is required for better explanation of the role of
this glycoprotein.
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Alsalem, 2019; Naga et al., 2019). The transformation rate
for oral leukoplakia into oral cancer in different parts of the
world is from 1–12% (Narayan and Shilpashree, 2016;
Warnakulasuriya, 2019). Important studies have shown that
OL may transform into squamous cell cancer in approxi-
mately 57 months. From the point of view of normal histol-
ogy, progenitor epithelial cells reach the surface of buccal
mucosa in 25 days, gingival — in 50 days, whereas in junc-
tion areas — rapidly in 5–6 days (Nanci, 2017, p. 80). Thus,
by biopsy medical staff capture only one moment in the
complicated course of hyperplasia and dysplasia of lining
mucosa. Animal models are not always acceptable for the
understanding of this long-term and complicated process
that leads to invasive carcinoma (Wielenga et al., 1993;
Herold- Mende et al., 1996)
However, for clinicians in dentistry it is still very important
to provide clear information about possible morphologic
and immunohistochemical predictive factors in oral leuko-
plakias and cancer (Godge and Poonja, 2011). Malignancies
involve important processes like proliferation, migration,
and loss of the adhesion of cells, and one of the molecules
reflecting these processes is CD44 antigen. During the last
years, CD44 has received names that describe its biochemi-
cal features: antiheparan sulfate proteoglycan, anti-
hyaluronate receptor antibody, hyaluronic acid receptor,
stem cell marker and anti-phagocytic glycoprotein I. Most
of the studies about the role of CD44 are associated with
malignancies. The CD44 family has more than 30 subtypes.
Some of its variants have been analysed in animal models
(Pals et al.,1993; Wielenga et al., 1993), in biopsy and sur-
gical material of malignancies in lymph nodes, skin, esoph-
agus, brain (Roye et al., 1996; Pettersen et al., 2011;
Jakovlevs et al., 2019) and particularly in head and neck tu-
mours (Boxberg et al., 2018; Tamatani et al., 2018). Corre-
lation between CD44 expression and prognosis, grade,
spread and T stage of oral squamous cell cancer has been
demonstrated (Kaza et al., 2018; Chen et al., 2019). How-
ever, scientists have mainly described a decreased amount
of CD44 adhesion molecules in oral cancer and only some
studies have demonstrated an increased amount of this anti-
gen in malignancies of the oral cavity (Lindquist et al.,
2012).
The role of CD44 antigen in oral leukoplakia is still contro-
versial. A few researchers have found an increased amount
of CD44 antigen in OL (Godge and Poonja, 2011), whereas
most have diagnosed a decreased amount of CD44 by calcu-
lating number of CD44-labelled cells manually, automati-
cally using traditional immunohistochemical methods with
immunoperoxidase, using Western blot analysis and even
flow cytometry (Miletti-Gonzalez et al., 2012; Chen et al.,
2019).
In the last years, CD44 antigen has been named also as a
stem cells marker of different organs (Pettersen et al., 2011;
Tamatani et al., 2018; Jakovlevs et al., 2019). However, it
is important to emphasise that there are three types of stem
cells: embryonic, adult and cancer ones. In oral leuko-
plakias and cancers there are possibly adult and cancer stem
cell variants, now called also tumour initiating cells (Naga
et al., 2019).
Participation of CD44 glycoprotein/anti-phagocytic glyco-
protein I of lymphocytes and macrophages in various in-
flammatory processes and autoimmune diseases in humans
and laboratory animals has also been described (Gore et al.,
2008; Johnson and Ruffell, 2009). CD44 molecules play an
active role in the immune reactions of nearby affected tis-
sues of pulp, skin, brain and other organs (Pisterna and
Siragusa, 2007; Pettersen et al., 2011; Jakovlevs et al.,
2019). Research groups have established a role of CD44 in
leucocyte recruitment to inflammatory sites and oral malig-
nancies (Groma et al., 2012). These studies also revealed a
role of CD44 in limiting the inflammatory response and re-
solving this process (Gore et al., 2008; Johnson and Ruffell,
2009).
There have been attempts of using anti-CD44 in experimen-
tal and practical medicine for the treatment of wounds, in-
flammation, and tumours (Negi et al., 2012; Reid et al.,
2019).
The aim of our study was to assess the amount and pattern
of CD44 antigen expression by epithelial and mononuclear
cells atoral leukoplakias and their role in potentially prema-
lignant lesions.
MATERIALS AND METHODS
Study group. The biopsies and surgical material of 102 pa-
tients with oral leukoplakia treated in the Department of
Oral Pathology, Rîga Stradiòð University Institute of
Stomatology and Centre of Maxillo-facial Surgery, Pauls
Stradiòð Clinical University Hospital was used in the cur-
rent study. The study included tissue samples examined by
two independent pathologists after hematoxylin-eosin stain-
ing. Ten biopsies from healthy oral mucosa were considered
as a control group. Gross and histopathological records of
the Pathology Institute, Pauls Stradiòð Clinical University
Hospital, were used to analyse the location and size of oral
leukoplakia, patients’ age, gender and previous anamnesis
of oral diseases. Our study was designed according to the
Helsinki Declaration. The study protocol was approved by
the Committee of Ethics of the Rîga Stradiòð University.
Morphological examination. Surgical material and biop-
sies of oral mucosa were fixed in 10% neutral (pH = 7) buf-
fered formalin solution, processed in a “Sakura Tissue-Tek
VIP 5”TM vacuum infiltration tissue processor and embed-
ded in paraplast (Diapath, Bergamo, Italy). All biopsies
from healthy and affected oral mucosa were stained with
haematoxylin-eosin. Paraffin blocks were cut in 4 µm-thick
sections; samples were placed on adhesive positively
charged slides. Then dewaxing and rehydration through al-
cohols to water was done.
Immunohistochemical examination. Immunohisto-
chemical CD44 antigen expression was determined by a
standard polymer-based visualisation system (EnVision
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method by Dako Denmark. clone DF1485, dilution 1 : 50.
For the detection of CD44 glycoprotein, 42 samples from
34 oral leukoplakias were chosen (two pieces of mucosa
were analysed from each surgical material), as well as ten
cases with healthy mucosa. For immunohistochemistry all
slides were incubated with 3% H202 for ten minutes to in-
hibit endogenous peroxidase activity. The micro-wave-
based antigen retrieval was performed in a freshly prepared
0.01 mol/l sodium citrate buffer (pH 6.0) solution at 750 W
for three cycles, for ten minutes each. Specimens were
immunostained using the primary antibody pan-CD44.
Slides were counterstained with Mayer’s hematoxylin, de-
hydrated in alcohol, cleared in xylene and cover-slipped.
CD44 antigen expression in epithelial cells and mono-
nuclear cells of lamina propria was considered positive if
more than 10% cells expressed a positive reaction. CD44
expression was diagnosed in lymphocytes, monocytes and
macrophages. The number of mononuclear cells in lamina
propria mucosae area under leukoplakia and epithelial cell
layers with CD44 antigen expression were counted in three
fields of vision using original magnification of 400× at
three different points of leukoplakia (both edges-locus 1 and
3 and central area-locus 2). Expression of CD44 was evalu-
ated semi-quantitatively as weak, mild, and strong — 1st,
2nd, and 3rd level of immunoexpression. Oral leukoplakia
was classified into homogenous and non-homogenous ac-
cording to the WHO classification, taking into consideration
its level of dysplasia — mild, moderate and severe. All
slides were examined and photographed with a Leica Mi-
croscope (Leitz, Wetzlar, Germany).
Statistical analysis. Calculations, statistical analyses, and
graph production were performed using the GraphPad Prism
software version 8.4.0 for Mac (GraphPad Software, San
Diego, CA, USA). The normality of numerical data was
checked using D’Agostino and Pearson and Shapiro-Wilk
tests, and if the data were not distributed normally, the
non-parametric Mann–Whitney test was used to compare
two groups. To compare three groups, the non-parametric
Kruskal–Wallis (KW) test followed by the two-stage step-
up method of Benjamini, Krieger, and Yekutieli as the
post-hoc procedure was applied. Mean levels of the parame-
ters were expressed as medians with dispersion, character-
ised by the interquartile region (IQR). Depending on the
data distribution, the correlation between variables was de-
termined by the parametric Pearson’s test (CD44 expression
in leukoplakia between three loci of epithelium) or by the
non-parametric Spearman’s test (CD44 expression in
leukoplakia and in normal mucosa; mononuclear cells in
leukoplakia and normal mucosa). The correlation between
the number of CD44 labelled epithelial layers and mono-
cytes in leukoplakia was determined by the Spearman’s test.
A p-value less than 0.05 (p < 0.05) was considered as a sta-
tistically significant difference.
RESULTS
Clinical and morphological characteristics. We analysed
biopsy and surgical material from 102 cases of oral
leukoplakia. The mean age of patients was 52.9 ± 14 (range
of 25–72) years. The ratio between male and female pa-
tients was 11 : 1. Oral leukoplakias were localised in 54.6%
of cases in buccal mucosa, 18.1% — on tongue and equally
9.1% on gingival mucosa, floor of the mouth and palate.
The size of the oral leukoplakias varied from 4 mm to 30
mm, with average size 14 mm ± 3.7 mm. In females the size
of oral leukoplakias was around 5 mm, but in males the av-
erage largest diameter of OL was 27 mm. Non-homogenous
leukoplakias were diagnosed in 10.5%, whereas others were
homogenous (89.5%). Oral epithelium of non-homogenous
leukoplakias was characterised by mild and moderate
dysplasia with characteristic changes of nuclei and altered
nucleo-cytoplasmatic ratio.
Immunohistochemical CD44 antigen characteristics. In
healthy mucosa, CD44 expression was positive in the mem-
branes with an average of five layers of epithelium, mainly
in the basal and in the intermediate layers but absent in the
surface cells. The mean number of CD44 labelled cells in
lamina propria mucosae of the control group was five. In
the homogenous oral leukoplakia, membranous expression
of glycoprotein was present in an average 17 layers of epi-
thelium and had the 1st and 2nd intensity level (Fig. 1) and
this difference was statistically significant (p < 0.0001)
(Fig. 2A). Three points in healthy mucosa and leukoplakia
were compared. In normal mucosa, CD44 expression in epi-
thelium did not statistically significantly differ between
three points of the samples (Fig. 2B). There was a statisti-
cally significant difference between locus 1 and locus 2 (p =
0.0224) and between locus 2 and locus 3 (p = 0.0019) of
oral leukoplakia. In the second locus-centre of OL, a
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Fig. 1. Overexpression of CD44 antigen in multiple epithelial layers of oral
leukoplakia (arrow), immunoperoxidase, anti-CD44, 100×.
smaller number of CD44 positive epithelial layers was ob-
served (Fig. 2 C).
In larger samples of surgically removed oral leukoplakias,
CD44 was expressed positively in ducts and acini of small
salivary glands. The amount of CD44 antigen was lower in
the dilated ducts with flattened atrophic epithelium (Fig. 3).
In 47% of non-homogenous oral leukoplakia where hyper-
plasia and dysplasia were present, there was not only mem-
branous expression of CD44, but this glycoprotein also oc-
curred in cytoplasm of the affected epithelium (Fig. 4).
CD44 expression was detected also in the mononuclear
cells under the basal membrane. In healthy oral mucosa, the
number of the labelled macrophages and leucocytes was on
average 5 in one field of vision (Fig. 5), with no significant
correlation between three points of the biopsy (Fig. 6B).
Under the leukoplakia, the number of CD44 labelled stro-
mal cells was on average 18 (Fig. 7) and the difference was
statistically significant (p < 0.0001) in comparison with the
control samples (p < 0.0001) (Fig. 6A). Moderate correla-
tion (p = 0.0045) between CD44 positive epithelial layers
and mononuclear cells of lamina propria mucosae with its
expression in the second locus (central part of leukoplakia)
was observed (Fig. 7C). We detected activation of stromal
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Fig. 2. A, Correlation of CD44 expression
level in normal mucosa (control) and in
leukoplakia. ****p < 0.0001; MW, Mann–
Whitney test. B, CD44 expression in epi-
thelium of normal mucosa in three differ-
ent points; C, CD44 expression in
epithelium of leukoplakia in three different
loci; *p < 0.05; **p < 0.01; KW, Kruskal–
Wallis test with Benjamini–Krieger–
Yekutieli post-hoc procedure.
Fig. 3. Different expression of CD44 antigen in the ducts and acini of
submucosal small salivary glands (arrows), Immunoperoxidase,
anti-CD44, 100×.
Fig. 4. Membranous and intra-cytoplasmatic presence (arrow) of CD44
glycoprotein in the epithelium of oral leukoplakia, immunoperoxidase,
anti-CD44, 400×.
Fig. 5. Few mononuclear cells with CD44 expression in lamina propria of
oral mucosa (arrow), immunoperoxidase, anti-CD44, 400×.
cells in lamina propria mucosae especially under the central
part of oral leukoplakia and observed that CD44 antigen ac-
cumulates simultaneously in the epithelium and lamina pro-
pria cells. This correlation was confirmed by the non-
parametric Spearman’s test (Fig. 8).
DISCUSSION
In the Baltic countries, oral and pharyngeal cancer is still di-
agnosed at the advanced stages of the disease. Based on the
EUCAN National register data, the highest incidence of the
oral and pharyngeal cancer in the Northern European coun-
tries is in Denmark — 910 (13.0), which is much higher
than in the Baltic states: Lithuania 387 (9.9); Estonia 143
(8.5) and Latvia — 215 (7.5). In terms of mortality, the
highest rates for 2012 were reported in Lithuania 286 (7.5)
followed by Estonia 110 (6.5) and Latvia 149 (5.4) (Diz et
al., 2017). This means that it is essential to identify markers
that could indicate the presence of early molecular changes
in such potentially premalignant tissues as oral leukoplakia.
In the European countries and USA, OL transforms into
OSCC less commonly than in Asia (Narayan et al., 2016;
Speight et al., 2018; Alsalem, 2019). It is important to
emphasise that potentially premalignant lesions and malig-
nancies of the oral cavity belong to the self-examinable neo-
plasia, and patients themselves must be involved in the de-
tection of visual or palpable changes of their oral mucosa.
The most important role in the diagnostics of OL is played
by a physician who must differentiate leukoplakias from
other white epithelial and non-epithelial lesions of the oral
cavity. Therefore, it is possible to exclude or accept poten-
tially premalignant oral lesions only by analysis of diagnos-
tic biopsies.
The patients of our study group were typically at the age be-
tween 50 and 70 years, and they were almost all male.
Therefore, we conclude that men’s lifestyle, harmful habits,
different environmental factors, and oral hygiene differ a lot
from those of females. The median age of the patients of
our study corresponded to the data from other studies
(Renaud-Vilmer and Cavelier, 2017; Naga et al., 2019). The
size of leukoplakia may be very different; even multiple
oral leukoplakias are described (Tamatani et al., 2018). In
our opinion, it is important to underline not only the diame-
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Fig. 6. A, number of CD44 positive mononuclear cells in healthy mucosa
and leukoplakia samples. p < 0.0001; MW, Mann–Whitney test; B,
Mononuclear cells of normal mucosa in three different points; C,
Mononuclear cells in lamina propria under leukoplakia in three different
points.
Fig. 8. Correlation between the number of CD44 labelled epithelium layers
and mononuclear cells in lamina propria under the central area of
leukoplakia (locus 2) performed by non-parametric Spearman’s test.
Fig. 7. A large number of laminae propria
mucosae mononuclear cells with intensive ex-
pression of CD44 antigen in them under
leukoplakia (arrow), immunoperoxidase,
anti-CD44, 200×.
ter of a white lesion but also its thickness. In thicker OL,
there is less maturation and differentiation of epithelium,
worse microcirculation, changed cell cycle and injury of
organelles, and therefore it is more likely that dysplasia will
develop and progress. Particularly larger and thicker OL
must be removed totally. In our group of patients, incom-
plete removal of OL was seen in 7% of cases. Conclusions
of a pathologist in multiple studies showed recurrence of
leukoplakia in 20% to even 73% of smokeless tobacco us-
ers (Godge and Poonja, 2011; Sundberg et al., 2019).
CD44-pan antigen is one of the adhesion molecules realis-
ing cell to cell interactions also in oral leukoplakia, but it
participates also in processes like inflammation, neoplasia,
autoimmune diseases and others (Puré and Oaff, 2001).
Oral cavity researchers had mainly concentrated on the role
of CD44 as a predictive and prognostic factor of oral
squamous cell cancer. Some research groups have found
that overexpression of CD44 correlates with wider dissemi-
nation, greater T stage and higher grade (Otriz et al., 2011;
Negi et al., 2012), but others have underlined that a de-
creased amount of CD44 is not associated with advanced
stages of oral cancer (Boxberg et al., 2018). Most authors
describe membranous location of the CD44 adhesion mole-
cule, and only a few have diagnosed its expression in cyto-
plasm (Groma et al., 2012; Kaza et al., 2018). In oral
leukoplakia, the results are even more controversial as dif-
ferent microscope magnifications have been used in patho-
histological examinations, various fields of vision and even
contrasting methods of counting. Our study group chose to
count the number of oral epithelia labelled with CD44 in
each leukoplakia, as this represents adhesion molecules in
leukoplakias of different thickness. Our statistical analyses
showed a statistically significant difference (p < 0.0001) be-
tween the number of CD44-labelled layers in normal and af-
fected mucosa. Therefore, we recommend this method of
counting for better evaluation of CD44 expression in studies
of potentially premalignant lesion and early carcinomas of
the oral cavity. We have showed CD44 intra-cytoplasmatic
immunoexpression in 47% of non-homogenous OL. This
phenomenon was shown in several studies of oral squamous
cell cancer (Khajuria and Metgud, 2015). Only a few au-
thors have described interaction of CD44 with the cyto-
skeleton (Harada and Takahashi, 2007; Miletti-Gonzalez, et
al., 2012). In our opinion, this fact possibly demonstrates
the expression of glycoprotein CD44 in the injured
mitochondrion, endoplasmatic reticulum or Golgi complex
of hyperplastic and dysplastic epithelium of oral leuko-
plakia, which needs to be verified by electronmicroscopic
examination of such leukoplakias. As CD44 is also a
marker of stem cells, membranous expression of glyco-
protein occurs in the adult stem and amplifying cells of oral
mucosa whereas cytoplasmatic labelling may be present in
single cells of oral leukoplakias. The pattern of CD44 ex-
pression in the cytoplasm of oral epithelium may be used as
a predictive factor for potential transformation of non-ho-
mogenous leukoplakia into an early stage of cancer. The
difference between the adult stem cells and the so-called
cancer stem cells is fragile and unstable, and can be demon-
strated only by immunohistochemistry, therefore, studies of
oral leukoplakias should include their genetic examinations
(Ambele et al., 2020). The CD44 antigen can bind growth
factors, hyaluronic acid, collagen, fibronectin, and metallo-
proteinases, and participation of CD44 in lymphocyte and
macrophage activation, leucocyte rolling and aggregation
has been described (Gore et al., 2008; Alves et al., 2009).
Therefore, it is of scientific interest that our results showed
a statistically significant difference (p < 0.0001) between
the mononuclear cells level in the lamina propria of normal
mucosa and leukoplakia samples. There was an increased
number of mononuclear cells (macrophages, monocytes,
and lymphocytes) under the basal membrane in the area of
OL and normal oral mucosa. Our statistical analyses
showed moderate correlation between the amount of
CD44-positive mononuclear cells in the lamina propria
mucosae and number of CD44-labelled oral epithelium lay-
ers in the central part of leukoplakia where more likely the
most active interactions between adhesion molecules are
found (p = 0.0045; r = 0.4758). Simultaneous accumulation
of CD44 antigen in the oral epithelium and stromal cells un-
der leukoplakia ensures its participation in the local im-
mune reactions, in long-term epithelial- mesenchymal in-
teractions as a hyaluronic receptor protein and anti-
phagocytic glycoprotein.
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CD44 ANTIGÇNA EKSPRESIJA UN TÂ LOKALIZÂCIJA KÂ ORÂLÂS LEIKOPLAKIJAS PROGNOSTISKAIS FAKTORS
Turpinâs ðûnu maríieru izpçte, kuri norâdîtu uz agrînâm molekulâram pârmaiòâm potenciâlos vçþdraudes audos, piemçram, mutes
leikoplakijâ (ML). Mûsu pçtîjuma mçríis bija noteikt CD44 ekspresijas daudzumu un tâ veidu ML epitçlijâ, izvçrtçjot tieði epitçlija slâòu
skaitu un gïotâdas saistaudu mononukleârâs ðûnâs un novçrtçt glikoproteîna lomu pirmsvçþa bojâjumos. Pçtîjumâ iekïâvâm 102
leikoplakiju biopsijas un operâciju materiâlus; kontroles grupâ bija 10 normâlas gïotâdas biopsijas. Imûnhistoíîmisku CD44 ekspresiju
noteica ar standarta vizualizâcijas sistçmu EnVision 42 paraugos no 34 ML. Statistiskâ analîze veikta, izmantojot GraphPad Prism
programatûru 8.4.0 versiju. Leikoplakiju gadîjumos tika pierâdîta statistiski ticama CD44 antigçna palielinâta ekspresija epitçlijâ, salîdzinot
ar neizmainîtu gïotâdu (p < 0.0001). CD44 ekspresija mutes epitçlija citoplazmâ kopâ ar raksturîgâm ðûnu kodolu izmaiòâm var bût kâ
prognozçjoðs faktors tieði nehomogçnas leikoplakijas potenciâlai malignizâcijai. Sinhrona CD44 antigçna palielinâðanâs mononukleârâs
ðûnâs zem bazâlâs membrânas leikoplakijas apvidû (p < 0.05), iespçjams regulç vçþdraudes audu tranformâciju intraepiteliâlâ mutes
gïotâdas vçzî, bet ir nepiecieðama tâlâka CD44 ekspresijas izpçte epitçlija intracitoplazmatiskajâs struktûrâs, lai labâk izskaidrotu ðî
glikoproteîna lomu.
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